BlackRock-advised Funds > BlackRock ETF Trust
BlackRock Future Health ETF
$4.04M
Avg Monthly Net Assets
$4.73M
Total Assets
$561K
Total Liabilities
$4.17M
Net Assets
BlackRock Future Health ETF is an Exchange-Traded Fund in BlackRock ETF Trust
from BlackRock-advised Funds,
based in Delaware,
United States of America.
The fund has one share class
and monthly net assets of $4.04M.
On September 27th, 2024 it reported 138 holdings, the largest
being BlackRock Funds III (6.5%), BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES (6.5%) and Boston Scientific Corp (3.6%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| BlackRock Future Health ETF | C000221226 | ARCX | BMED |
Holdings
From latest NPORT-P, filed September 27th, 2024 for period ending July 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 10X Genomics Inc | Long | Equity-common | US | $11K | 508 | 0.25 |
| 4D Molecular Therapeutics Inc | Long | Equity-common | US | $4K | 235 | 0.10 |
| AC Immune SA | Long | Equity-common | CH | $7K | 2K | 0.16 |
| Align Technology Inc | Long | Equity-common | US | $58K | 248 | 1.38 |
| Alkermes PLC | Long | Equity-common | IE | $11K | 399 | 0.26 |
| Allogene Therapeutics Inc | Long | Equity-common | US | $5K | 2K | 0.11 |
| Alnylam Pharmaceuticals Inc | Long | Equity-common | US | $108K | 455 | 2.59 |
| Amgen Inc | Long | Equity-common | US | $101K | 304 | 2.43 |
| Apellis Pharmaceuticals Inc | Long | Equity-common | US | $4K | 113 | 0.11 |
| Arcturus Therapeutics Holdings Inc | Long | Equity-common | US | $5K | 226 | 0.13 |
| Arcus Biosciences Inc | Long | Equity-common | US | $6K | 345 | 0.14 |
| Argenx SE | Long | Equity-common | NL | $111K | 216 | 2.68 |
| Arrowhead Pharmaceuticals Inc | Long | Equity-common | US | $5K | 167 | 0.11 |
| Arvinas Inc | Long | Equity-common | US | $13K | 479 | 0.32 |
| AstraZeneca PLC | Long | Equity-common | GB | $35K | 439 | 0.83 |
| Autolus Therapeutics PLC | Long | Equity-common | GB | $8K | 2K | 0.19 |
| Avidity Biosciences Inc | Long | Equity-common | US | $12K | 263 | 0.29 |
| Axsome Therapeutics Inc | Long | Equity-common | US | $7K | 75 | 0.16 |
| Beam Therapeutics Inc | Long | Equity-common | US | $19K | 611 | 0.46 |
| Becton Dickinson & Co | Long | Equity-common | US | $22K | 90 | 0.52 |
| BeiGene Ltd | Long | Equity-common | KY | $30K | 181 | 0.72 |
| Bicycle Therapeutics PLC | Long | Equity-common | GB | $5K | 204 | 0.12 |
| Bio-Techne Corp | Long | Equity-common | US | $79K | 963 | 1.89 |
| Biogen Inc | Long | Equity-common | US | $48K | 225 | 1.15 |
| Biohaven Ltd | Long | Equity-common | VG | $9K | 238 | 0.22 |
| BioMarin Pharmaceutical Inc | Long | Equity-common | US | $79K | 936 | 1.90 |
| Biomea Fusion Inc | Long | Equity-common | US | $2K | 305 | 0.04 |
| Black Diamond Therapeutics Inc | Long | Equity-common | US | $11K | 2K | 0.27 |
| BlackRock Cash Funds: Institutional, SL Agency Shares (BlackRock Funds III) | Long | Short-term investment vehicle | US | $271K | 270K | 6.49 |
| BlackRock Cash Funds: Treasury, SL Agency Shares (BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES) | Long | Short-term investment vehicle | US | $270K | 270K | 6.48 |
| Blueprint Medicines Corp | Long | Equity-common | US | $39K | 357 | 0.93 |
| Boston Scientific Corp | Long | Equity-common | US | $151K | 2K | 3.61 |
| Bridgebio Pharma Inc | Long | Equity-common | US | $10K | 386 | 0.24 |
| Cabaletta Bio Inc | Long | Equity-common | US | $8K | 1K | 0.19 |
| Catalent Inc | Long | Equity-common | US | $21K | 362 | 0.52 |
| Cencora Inc | Long | Equity-common | US | $145K | 609 | 3.48 |
| CG oncology Inc | Long | Equity-common | US | $4K | 128 | 0.10 |
| Charles River Laboratories International Inc | Long | Equity-common | US | $36K | 146 | 0.86 |
| CONMED Corp | Long | Equity-common | US | $14K | 204 | 0.34 |
| CONTRA ABIOMED INC | Long | Rights | US | $398.52 | 246 | 0.01 |
| CONTRA FREQUENCY THERA | Long | Rights | US | $0 | 420 | – |
| CONTRA MIRATI THERAPEU | Long | Rights | US | $237.14 | 334 | 0.01 |
| ConvaTec Group PLC | Long | Equity-common | GB | $26K | 9K | 0.62 |
| Cooper Cos Inc/The | Long | Equity-common | US | $43K | 466 | 1.04 |
| Danaher Corp | Long | Equity-common | US | $85K | 306 | 2.04 |
| Denali Therapeutics Inc | Long | Equity-common | US | $24K | 990 | 0.58 |
| Dexcom Inc | Long | Equity-common | US | $9K | 133 | 0.22 |
| Dyne Therapeutics Inc | Long | Equity-common | US | $18K | 427 | 0.44 |
| Edwards Lifesciences Corp | Long | Equity-common | US | $46K | 729 | 1.10 |
| Elevance Health Inc | Long | Equity-common | US | $42K | 79 | 1.01 |
| Encompass Health Corp | Long | Equity-common | US | $17K | 188 | 0.42 |
| Exact Sciences Corp | Long | Equity-common | US | $11K | 249 | 0.27 |
| Exelixis Inc | Long | Equity-common | US | $26K | 1K | 0.62 |
| Galapagos NV | Long | Equity-common | BE | $8K | 309 | 0.20 |
| Genmab A/S | Long | Equity-common | DK | $16K | 58 | 0.39 |
| Genmab A/S | Long | Equity-common | DK | $5K | 189 | 0.13 |
| Gerresheimer AG | Long | Equity-common | DE | $59K | 572 | 1.42 |
| Glaukos Corp | Long | Equity-common | US | $11K | 91 | 0.26 |
| Guardant Health Inc | Long | Equity-common | US | $28K | 796 | 0.67 |
| Halozyme Therapeutics Inc | Long | Equity-common | US | $20K | 354 | 0.47 |
| Helix Acquisition Corp II | Long | Equity-common | KY | $12K | 1K | 0.28 |
| Hologic Inc | Long | Equity-common | US | $33K | 408 | 0.80 |
| ICON PLC | Long | Equity-common | IE | $24K | 72 | 0.57 |
| Immatics NV | Long | Equity-common | NL | $7K | 570 | 0.16 |
| Immunocore Holdings PLC | Long | Equity-common | GB | $27K | 672 | 0.64 |
| Incyte Corp | Long | Equity-common | US | $16K | 250 | 0.39 |
| Insmed Inc | Long | Equity-common | US | $45K | 619 | 1.08 |
| Inspire Medical Systems Inc | Long | Equity-common | US | $26K | 184 | 0.62 |
| Intuitive Surgical Inc | Long | Equity-common | US | $117K | 264 | 2.82 |
| Ionis Pharmaceuticals Inc | Long | Equity-common | US | $18K | 363 | 0.43 |
| Keros Therapeutics Inc | Long | Equity-common | US | $9K | 174 | 0.21 |
| Kyverna Therapeutics Inc | Long | Equity-common | US | $1K | 127 | 0.03 |
| Labcorp Holdings Inc | Long | Equity-common | US | $31K | 142 | 0.73 |
| Legend Biotech Corp | Long | Equity-common | KY | $50K | 878 | 1.19 |
| Lexeo Therapeutics Inc | Long | Equity-common | US | $753 | 60 | 0.02 |
| Longboard Pharmaceuticals Inc | Long | Equity-common | US | $2K | 63 | 0.05 |
| Lonza Group AG | Long | Equity-common | CH | $35K | 52 | 0.83 |
| MacroGenics Inc | Long | Equity-common | US | $1K | 386 | 0.03 |
| Masimo Corp | Long | Equity-common | US | $57K | 536 | 1.38 |
| McKesson Corp | Long | Equity-common | US | $72K | 116 | 1.72 |
| Merck & Co Inc | Long | Equity-common | US | $19K | 164 | 0.45 |
| Merus NV | Long | Equity-common | NL | $44K | 834 | 1.06 |
| Mettler-Toledo International Inc | Long | Equity-common | US | $105K | 69 | 2.52 |
| Molina Healthcare Inc | Long | Equity-common | US | $55K | 161 | 1.32 |
| Monte Rosa Therapeutics Inc | Long | Equity-common | US | $1K | 230 | 0.02 |
| MoonLake Immunotherapeutics | Long | Equity-common | KY | $10K | 237 | 0.24 |
| Morphic Holding Inc | Long | Equity-common | US | $9K | 162 | 0.22 |
| Natera Inc | Long | Equity-common | US | $25K | 240 | 0.59 |
| Neumora Therapeutics Inc | Long | Equity-common | US | $3K | 218 | 0.07 |
| Neurocrine Biosciences Inc | Long | Equity-common | US | $51K | 360 | 1.22 |
| Novocure Ltd | Long | Equity-common | JE | $9K | 402 | 0.22 |
| Nurix Therapeutics Inc | Long | Equity-common | US | $19K | 884 | 0.46 |
| Nuvalent Inc | Long | Equity-common | US | $38K | 480 | 0.92 |
| Nuvation Bio Inc | Long | Equity-common | US | $3K | 718 | 0.07 |
| Nyxoah SA | Long | Equity-common | BE | $8K | 946 | 0.19 |
| ORIC Pharmaceuticals Inc | Long | Equity-common | US | $6K | 509 | 0.14 |
| Penumbra Inc | Long | Equity-common | US | $22K | 129 | 0.52 |
| Perspective Therapeutics Inc | Long | Equity-common | US | $6K | 433 | 0.14 |
| Prime Medicine Inc | Long | Equity-common | US | $4K | 751 | 0.10 |
| Protagonist Therapeutics Inc | Long | Equity-common | US | $33K | 869 | 0.78 |
| PTC Therapeutics Inc | Long | Equity-common | US | $16K | 479 | 0.39 |
| QIAGEN NV | Long | Equity-common | NL | $74K | 2K | 1.78 |
| RadNet Inc | Long | Equity-common | US | $8K | 142 | 0.20 |
| REGENXBIO Inc | Long | Equity-common | US | $3K | 234 | 0.08 |
| Repligen Corp | Long | Equity-common | US | $36K | 214 | 0.86 |
| REVOLUTION Medicines Inc | Long | Equity-common | US | $32K | 704 | 0.77 |
| Rhythm Pharmaceuticals Inc | Long | Equity-common | US | $56K | 1K | 1.34 |
| Roche Holding AG | Long | Equity-common | CH | $16K | 49 | 0.38 |
| Rocket Pharmaceuticals Inc | Long | Equity-common | US | $17K | 698 | 0.41 |
| Roivant Sciences Ltd | Long | Equity-common | BM | $21K | 2K | 0.49 |
| Sage Therapeutics Inc | Long | Equity-common | US | $6K | 540 | 0.14 |
| Sagimet Biosciences Inc | Long | Equity-common | US | $3K | 867 | 0.07 |
| Sanofi SA | Long | Equity-common | FR | $31K | 605 | 0.75 |
| Sarepta Therapeutics Inc | Long | Equity-common | US | $49K | 347 | 1.19 |
| Sartorius AG | Long | Equity-preferred | DE | $29K | 104 | 0.71 |
| Soleno Therapeutics Inc | Long | Equity-common | US | $11K | 219 | 0.25 |
| STERIS PLC | Long | Equity-common | IE | $23K | 98 | 0.56 |
| Stoke Therapeutics Inc | Long | Equity-common | US | $17K | 1K | 0.40 |
| Structure Therapeutics Inc | Long | Equity-common | KY | $5K | 142 | 0.13 |
| Stryker Corp | Long | Equity-common | US | $63K | 192 | 1.51 |
| Tandem Diabetes Care Inc | Long | Equity-common | US | $11K | 288 | 0.26 |
| Tarsus Pharmaceuticals Inc | Long | Equity-common | US | $8K | 333 | 0.19 |
| Tenaya Therapeutics Inc | Long | Equity-common | US | $2K | 623 | 0.05 |
| Thermo Fisher Scientific Inc | Long | Equity-common | US | $67K | 110 | 1.62 |
| TScan Therapeutics Inc | Long | Equity-common | US | $16K | 2K | 0.38 |
| Twist Bioscience Corp | Long | Equity-common | US | $16K | 287 | 0.38 |
| Ultragenyx Pharmaceutical Inc | Long | Equity-common | US | $11K | 250 | 0.27 |
| United Therapeutics Corp | Long | Equity-common | US | $43K | 136 | 1.02 |
| UnitedHealth Group Inc | Long | Equity-common | US | $74K | 129 | 1.78 |
| Vaxcyte Inc | Long | Equity-common | US | $50K | 631 | 1.20 |
| Vertex Pharmaceuticals Inc | Long | Equity-common | US | $23K | 46 | 0.55 |
| Vigil Neuroscience Inc | Long | Equity-common | US | $2K | 475 | 0.05 |
| Viking Therapeutics Inc | Long | Equity-common | US | $5K | 93 | 0.13 |
| Voyager Therapeutics Inc | Long | Equity-common | US | $7K | 779 | 0.17 |
| Waters Corp | Long | Equity-common | US | $69K | 206 | 1.66 |
| West Pharmaceutical Services Inc | Long | Equity-common | US | $103K | 337 | 2.48 |
| Xenon Pharmaceuticals Inc | Long | Equity-common | CA | $43K | 990 | 1.03 |
| Zealand Pharma A/S | Long | Equity-common | DK | $48K | 353 | 1.14 |
Address
BlackRock ETF Trust
100 BELLEVUE PARKWAY
WILMINGTON
Delaware
19809
United States of America
Websites
Directors
Cynthia A. Montgomery
Kenneth L. Urish
John M. Perlowski
Mark Stalnecker
Susan J. Carter
Donald C. Opatrny
Henry R. Keizer
Lena G. Goldberg
Claire A. Walton
Lori Richards
Collette Chilton
Robert Fairbairn
Neil A. Cotty
Transfer Agents
State Street Bank and Trust Company
Pricing Services
S&P Global Inc.
Bloomberg L.P.
London Stock Exchange Group PLC
ICE Data Services, Inc.
Custodians
State Street Bank and Trust Company (Edinburgh, GB, Branch)
Citibank, National Association (Sao Paulo, Sao Paulo, BR, Branch)
BNP Paribas
Standard Chartered Bank (Hong Kong) Limited
Royal Bank of Canada
Intesa Sanpaolo S.p.A.
Bank Hapoalim B.M.
UniCredit Bank Hungary Zrt.
Euroclear Bank
Banco Nacional de Mexico, S.A., Integrante del Grupo Financiero Banamex
BNP Paribas (Athens, Attica, GR, Branch)
State Street Bank International GmbH
Deutsche Bank Aktiengesellschaft (Jakarta, Jakarta, ID, Branch)
UBS Switzerland AG
Skandinaviska Enskilda Banken AB (Oslo, Oslo, NO, Branch)
Standard Chartered Bank Malaysia Berhad
Citibank, National Association (Mumbai, Maharashtra, IN, Branch)
Mizuho Bank, Ltd. (Minato ku, Tokyo, JP, Branch)
Citibank, National Association (Ciudad Autonoma de Buenos Aires, Ciudad Autonoma de Buenos Aires, AR, Branch)
HSBC Bank (China) Company Limited
Bank Handlowy w Warszawie Spolka Akcyjna
UniCredit Bank Austria AG
Citibank Europe Public Limited Company
Deutsche Bank Aktiengesellschaft (Makati City, Metro Manila, PH, Branch)
The Hongkong and Shanghai Banking Corporation Limited (Jung-gu, Seoul, KR, Branch)
The Hongkong and Shanghai Banking Corporation Limited
The Hongkong and Shanghai Banking Corporation Limited (Sydney, NSW, AU, Branch)
Deutsche Bank Aktiengesellschaft (Taipei City, TW, Branch)
Skandinaviska Enskilda Banken AB
Standard Chartered Bank (Thai) Public Company Limited
State Street Bank and Trust Company
Skandinaviska Enskilda Banken AB (Helsinki, Uusimaa, FI, Branch)
Skandinaviska Enskilda Banken AB (Copenhagen, Hovedstaden, DK, Branch)
Citibank, National Association (Singapore, SG, Branch)
The Hongkong and Shanghai Banking Corporation Limited (Auckland, Auckland, NZ, Branch)
FirstRand Bank Limited
State Street Trust Company Canada
Shareholder Servicing Agents
N/A
Admins
State Street Bank and Trust Company
Brokers
J.P. Morgan Securities LLC
Jefferies LLC
BofA Securities, Inc.
Cowen and Company, LLC
Morgan Stanley & Co. LLC
Citigroup Global Markets Inc.
UBS Securities LLC
Barclays Capital Inc.
Goldman Sachs & Co. LLC
Nomura Securities International, Inc.